A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Go Omniglass with Swoop’s TV marketing solutions. Bridge audience fragmentation and maximize your TV strategy across leading channel partners with our omniglass offering.
Unlock your brand.com first-party data potential. Swoop’s award winning chatbot transforms site level engagement into valuable first-party data with conversational AI.
Swoop Wins 2025 Business Intelligence Group Award, Building on Momentum of Triple PM360 Innovation Recognition
Honored by innovation awards from the BIG and PM360, Swoop’s predictive audiences showcase how pharmaceutical marketing can help improve patient’s health outcomes.
Optimizing TV Targeting in a Fragmented Landscape Advances Better Patient Outcomes
Connecting with the right audiences with precision and impact across all channels allows pharmaceutical companies to enhance patient engagement and drive better health outcomes. In addition to helping patients by connecting them with new information, consumer ads positively influence healthcare providers (HCP) prescribing behavior.
DSP Diagnosis: 10 Factors Pharma Marketers Should Consider
In today’s complex healthcare marketing landscape, selecting the right Demand-Side Platform (DSP) is crucial for pharmaceutical brands aiming to deliver impactful, targeted, and compliant omnichannel campaigns to patients and healthcare providers (HCPs). This checklist will guide you through the essential factors to consider, ensuring that your chosen DSP aligns with your marketing objectives, respects patient […]
Celebrating the innovative and impactful use of conversational AI technology, CUSTOMER magazine awarded Swoop a 2024 Conversational AI Excellence Award.
Swoop's new conversational AI platform allows pharma brands to engage in 24/7, MLR-compliant near-human interaction with ideal customers in the moment of need.
Swoop has just launched its audience building with predictive AI segments to create ideal DTC and HCP segments for proactive engagement at critical moments in the health journey.
Swoop’s privacy-safe patient segments can now be used by healthcare marketers to plan activation across iHeartMedia’s industry-leading broadcast radio ecosystem.
Swoop re-imagines traditional 1:1 HCP advertising using ML/AI in conjunction with RWD to uncover critical brand ambassadors that are typically overlooked.
W2O acquires Swoop, the leader in AI generated digital health audiences trusted by 42 of the top 50 brands & 18 of the top 20 healthcare marketing agencies
Swoop's patented system of engagement uses privacy-safe ML & AI in conjunction with RWD to create precise patient & healthcare provider target audiences